If your dog chewed a GLP-1 pen, swallowed tablets, or received a mistaken injection, contact a veterinarian or animal poison-control service with the exact product now. Vomiting, diarrhea, poor appetite, and lethargy are commonly reported after pet exposures, while the pen, needle, glass, plastic, and any other ingredients create separate risks.
Identify the medicine before interpreting the signs
Start with the active ingredient, not the color of the tablet or the reason a person takes it. Drugs that share a cabinet, a brand family, or a general purpose can act on completely different body systems. Find the original bottle or pharmacy record, and do not rely on a pill-identification guess when the package can be recovered.
Call a veterinarian, emergency hospital, or animal poison-control service promptly with the exact name, strength, formulation, possible amount, time, and the dog's weight. A normal appearance immediately after access is not a reason to wait: the useful assessment starts with exposure facts, and some formulations release medicine over many hours.
| Medicine or subgroup | Why the distinction matters | Details to report |
|---|---|---|
| Semaglutide | Sold in injectable and oral forms; the route and strength must be identified. | Brand, tablet or pen, concentration/strength, amount |
| Tirzepatide | A dual GIP/GLP-1 medicine; do not assume a semaglutide exposure plan applies. | Brand, pen/vial, amount missing, device damage |
| Liraglutide | Typically supplied in a multi-dose pen, so the remaining volume may be more useful than counting devices. | Pen strength, estimated missing volume, needle status |
| Dulaglutide | A prefilled device can combine medicine exposure with swallowed or sharp components. | Device type, whether activated, fragments recovered |
What this medication family changes in the body
GLP-1 medicines influence appetite, stomach emptying, and glucose regulation. ASPCA Poison Control lists semaglutide, tirzepatide, liraglutide, and dulaglutide among increasingly encountered pet exposures and reports gastrointestinal signs and lethargy most often. It also notes that research is ongoing and these products are not currently approved for veterinary use.
That evidence supports prompt professional assessment, not a dog-specific dose calculation from a human pen. Different agents, concentrations, routes, and combination treatments can change the concern. A compounded vial or “GLP-1-like” supplement must be treated as its own product because the label may contain ingredients beyond the name on the advertisement.
What an owner may notice—and what can stay hidden
Vomiting, diarrhea, reduced appetite, and lethargy are the most commonly reported pet signs in ASPCA's alert. Low blood sugar and pancreatitis are described as less common but possible complications. Repeated vomiting, abdominal pain, profound weakness, collapse, tremors, or seizures should be reported as emergency signs rather than watched for a trend.
A chewed injection pen or vial adds mechanical hazards: a needle can puncture tissue, and swallowed plastic, metal, or glass may injure or obstruct the gastrointestinal tract. Do not sweep blindly inside the dog's mouth. Photograph the device, collect visible fragments safely, and tell the team whether a needle is unaccounted for.
Why two apparently similar exposures can get different advice
A lick of residue, a swallowed tablet, a chewed unused pen, and an accidental injection are four different routes. The package can show whether the device was unused, partly used, or already empty, but do not test-fire or dismantle it to estimate the dose. Preserve it in a rigid container if a sharp remains exposed.
GLP-1-like gummies or powders may contain 5-HTP, caffeine, xylitol, or other ingredients. ASPCA specifically warns that these supplements are variable. Send the complete label, not merely a product claim, and use the xylitol product guide if xylitol appears while you call.
- The active ingredient and tablet or liquid strength, including every ingredient in a combination product.
- Immediate-release, delayed-release, extended-release, patch, cream, pen, or other formulation wording.
- The maximum that could be missing, the earliest and latest possible access time, and whether more than one dog had access.
- The dog's current weight, age, symptoms, heart or kidney disease, diabetes, and every prescription or supplement already given.
- Chewed plastic, foil, glass, needles, cartridges, or other packaging that creates an injury or obstruction question separate from the drug.
Build a useful exposure record while you call
Photograph the front label, prescription panel, active ingredients, and remaining contents. Count what remains only if that can be done safely; report an honest range when the original count is uncertain. The poison-control call checklist can keep those details in one place without delaying the call.
Describe observations instead of conclusions: write “stumbled twice at 2:10” rather than “overdosed,” and record vomiting, urination, thirst, breathing, alertness, tremors, gum color, and changes in sequence. Merck's poisoning-diagnosis guidance emphasizes the exposure history and order of signs because those facts help a clinician choose monitoring and tests.
FDA advises placing used needles and pens in a suitable sharps container immediately and keeping that container away from pets. If the dog chewed a disposal container, tell the veterinary team about every possible medicine and needle inside; this is not just a GLP-1 exposure.
Why this guide gives no dose or home antidote
A toxicity threshold copied from one drug cannot be transferred to another member of the family, and a number without formulation, patient history, and timing can encourage a dangerous delay. This page therefore does not calculate a “safe” amount, diagnose poisoning, or prescribe a home treatment.
Do not induce vomiting, give activated charcoal, force food or water, or add another medicine unless the veterinary professional managing this exact exposure directs it. Vomiting can be unsafe when a dog is already sleepy, agitated, weak, seizuring, unable to swallow normally, or exposed to a formulation that changes aspiration risk. Use the first 10 minutes guide for safe information-gathering steps while help is arranged.
Prevent the second exposure
FDA advises keeping medicines in their original, labeled containers and in genuinely secure storage. Countertops, bedside tables, handbags, weekly organizers, and parcels are common access points because a dog can pull down, crush, or chew containers that seem closed. Separate human and animal medicines, and do not pre-sort pills into an unlabeled bag when a labeled container can travel with them.
After the immediate case is handled, reconcile the remaining medication with the pharmacy record and clean up fragments where pets cannot reach them. Use a take-back or label-directed disposal route, secure sharps in an appropriate container, and give caregivers a written medication handover. Prevention is part of the medical record: knowing exactly how access occurred makes the next container easier to protect.
Available 24/7. A consultation fee may apply.
Frequently asked questions
What symptoms are reported after pet GLP-1 exposures?
ASPCA lists vomiting, diarrhea, lethargy, and decreased appetite most often, with low blood sugar and pancreatitis described as less common possible complications. The exact product and route still need professional assessment.
Is a used injection pen harmless?
No. Residual medicine may remain, and the needle, plastic, metal, or glass can cause puncture, injury, or obstruction. Secure the device without dismantling it and report missing parts.
Are GLP-1-like supplements the same as prescriptions?
No. ASPCA warns that supplement formulations vary and may include 5-HTP, xylitol, caffeine, or other concerning ingredients. Photograph the full ingredient panel and treat it as a separate exposure.
Should I wait for symptoms if my dog looks normal?
No. Call with the exact product and exposure estimate. Some effects are delayed, and early decisions depend on the drug, formulation, possible amount, time, weight, and current condition rather than on visible illness alone.
Can I make my dog vomit after a pill exposure?
Only if the veterinarian or animal poison specialist handling the case specifically directs it. Neurologic depression, agitation, swallowing difficulty, the formulation, and the time since access can all make vomiting unsafe or unhelpful.
What if I cannot tell how many tablets are missing?
Report the uncertainty rather than choosing a reassuring number. Bring the bottle, remaining pills, refill date, prescribed schedule, possible access window, dog's weight, symptoms, and information about any other pet that could have reached it.